20266 ⎘
Medicinal preparations containing organic active ingredients; Esters, e.g. nitroglycerine, selenocyanates Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
Adamantyl derivatives as therapeutic agents
#302COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING CANCER BY TARGETING AND INHIBITING CANCER STEM CELLS
#303Methods and compositions for treatment of autism
#304Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
#305Use of isothiocyanates for treating cancer
#306Method for delivery and use of isothiocyanates for prophylaxis and/or therapy of bladder cancer
#307COMPOSITIONS AND METHODS FOR REVERSING CORTICOSTEROID RESISTANCE OR TREATING RESPIRATORY INFECTIONS
#308Methods for Treating Inflammation and Oxidative Stress Related Diseases
#309Compositions and methods for epigenetic modification of nucleic acid sequences
#310ANTI-MICROBIAL ORTHODONTIC COMPOSITIONS AND APPLIANCES AND METHODS OF PRODUCTION AND USE THEREOF
#311SYNERGISTIC INHIBITION OF LOW-DENSITY LIPOPROTEIN OXIDATION
#312METHODS FOR PROTECTING THE SKIN FROM RADIATION INSULTS
#313INHIBITING STOMACH-ACID RELEASE, REDUCING INFLAMMATION AND PREVENTING AND TREATING CANCER: COMPOSITIONS AND METHODS OF USE
#314Method for treating a keratoconjunctival disorder
#315METHODS AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING PSORIASIS
#316Method to Detect or Treat Painful Bladder Syndrome based on Relation to Quinone Oxidoreductase 1
#317Method for treating psoriasis
#318Method for treating eczema
#319Method for treating phytophotodermatitis
#320SKIN BARRIER FUNCTION RECOVERY ACCELERATOR
#321Compositions and methods relating to proliferative diseases
#322Use of isothiocyanates compounds in treating prostatic diseases and skin cancer
#323METHODS AND COMPOSITIONS FOR ENHANCING SURVIVABILITY OF CELLS, TISSUES, ORGANS AND ORGANISMS
#324Targeting of Histone Deacetylase 2, Protein Kinase CK2, and Nuclear Factor NRF2 For Treatment of Inflammatory Diseases
#325Method of screening for a substance that strengthens a bond between thioredoxin and macrophage migration inhibition factor
#326TREATMENT
#327Enhanced lactoperoxidase system for treatment of milk products
#328SMALL MOLECULE MODULATORS OF PRONGF UPTAKE
#329Di-fluoro containing compounds as cysteine protease inhibitors
#330Methods and Compositions for the Treatment of Cystic Fibrosis and Related Illnesses
#331Use of isothiocyanate derivatives as anti-myeloma agents
#332METHODS FOR PROTECTING THE SKIN FROM RADIATION INSULTS
#333Preparation and use of sleeve and micro-encapsulated topical analgesic patch for treating pain
#334USE OF NRF2 INDUCERS TO TREAT EPIDERMOLYSIS BULLOSA SIMPLEX AND RELATED DISEASES
#335TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH AN ANTINEOPLASTIC HEAT SHOCK APOPTOSIS ACTIVATOR (HSAA)
#336COMBINATION BETWEEN AN ISOTHIOCYANATE AND LEVODOPA FOR PARKINSON'S DISEASE TREATMENT
#337Thyroid protection in sickle cell anemia treatment
#338Aldehyde dehydrogenase inhibitors as novel depigmenting agents
#339AGENTS FOR TREATMENT OF DIABETIC RETINOPATHY AND DRUSEN FORMATION IN MACULAR DEGENERATION
#340SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF
#341Potent inhibitory effect of zinc in combination with sulforaphane on cancer cell growth
#342SELENIUM-BASED BIOCIDAL FORMULATIONS AND METHODS OF USE THEREOF
#343SELENIUM-BASED BIOCIDAL FORMULATIONS AND METHODS OF USE THEREOF
#344COSMETIC PRODUCT FOR THE TREATMENT OF CICATRICIAL TISSUES
#345Phosphate binding materials and their uses
#346Anti-microbial orthodontic compositions and appliances and methods of production and use thereof
#347PHASE 2 INDUCERS AND RELATED SIGNALING PATHWAYS PROTECT CARTILAGE AGAINST INFLAMMATION/INFECTION, APOPTOSIS AND STRESS
#348FORMULATIONS OF RADIOPROTECTIVE ALPHA BETA UNSATURATED ARYL SULFONES
#349Method for determining physiological effects of hemoglobin
#350DEVICE FOR THE TREATMENT OF CAROTID ARTERY DISEASES
#351Modulation of the Cooperativity Between the Ion Channels TRPM5 and TRPA1
#352Screening method, a composition comprising substances chosen in the method thereof, and a binding substance
#353Method for treating a keratoconjunctival disorder
#354Counteracting drug-induced obesity using GLP-1 agonists
#355Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes
#356Use of isothiocyanates compounds in treating prostatic diseases and skin cancer
#357ANTI-CANCER COMPOSITIONS AND METHODS
#358Di-fluoro containing compounds as cysteine protease inhibitors
#359Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
#360Stabilized sulforaphane
#361Methods, Compositions and Articles of Manufacture for Enhancing Survivability of Cells, Tissues, Organs, and Organisms
#362Methods, Compositions and Articles of Manufacture for Enhancing Survivability of Cells, Tissues, Organs, and Organisms
#363INHIBITING CYP3A4 INDUCTION
#364Methods and pharmaceutical compositions useful for treating psoriasis
#365Use of a liquid cooling sensate to provide a pungent, warming or tingling sensate composition
#366Selenium-based biocidal formulations and methods of use thereof
#367A LIPIDIC EXTRACT FROM LEPIDIUM MEYNII AND ITS EFFECT ON THE LIBIDO
#368Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms
#369Methods and composition for the treatment of cystic fibrosis and related illnesses
#370Compositions and methods for treating lung cancer
#371Micro/nanoparticle obtained from lipid-containing marine organisms for use in pharmaceutics and cosmetics
#372Dietary supplement including He Shou Wu, parasitic loranthus and green tea to promote weight loss
#373Method for inhibition or treatment of colon tumorigenesis
#374Methods and compositions for treatment of central nervous system injury with isothiocyanates
#375Irreversible selective androgen receptor modulators and methods of use thereof
#376Nitrate esters and their use for mitigating cellular damage
#377Agents for treatment of diabetic retinopathy and drusen formation in macular degeneration
#378Method of treating breast cancer with androgen receptor antagonists
#379Method of modulating immune response by administration of immuno-activation agent
#380Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes
#381Curcumin compositions and methods of use as an NK3 antagonist